Featured Articles

Coping with Bell's Palsy

The following article presents the very latest information on Bell's Palsy. If you have a particular interest in Bell's,...

Herbal sedative recalled - Sleeping...

A dietary supplement was recalled after FDA determined that the product contained a prescription-strength sedative no...

A comparison of antihistamines - Hi...

Several antihistamines prescribed for people with seasonal allergic rhinitis are advertised as nonsedating, primarily Hi...

Causes and Effects of Xanax Abuse b...

Xanax is prescription tranquilizer which depresses the nervous system in a way similar to alcohol. It is also known as...

Ampicillin Medicine - Uses, Dosage ...

Ampicillin is an antibiotic belongs to the class of drugs known as penicillins. Ampicillin is used to treat certain inf...

FIND A DRUG

Pharmacy Locator

ZIP Distance

Use this tool to find
pharmacies in your area

FDA News Release

Consumer Updates

Fda Approves Atrix's Prostate Cancer Product | Worldwide Biotech | Find ...

Back

Atrix Laboratories, Inc. (Nasdaq: ATRX), Fort Collins, Colo., has received approval from the FDA for Eligard(TM) 7.5 mg (formerly Leuprogel One-Month Depot), leuprolide acetate for subcutaneous injection for treatment of advanced prostate cancer. Atrix and Sanofi-Synthelabo Inc., Atrix's marketing partner for the Eligard product line, anticipates this new therapy will be an important addition in the fight against prostate cancer.